Published in Eur J Clin Pharmacol on October 19, 2005
Statins in the primary prevention of cardiovascular disease. Nat Rev Cardiol (2013) 1.12
Can postponement of an adverse outcome be used to present risk reductions to a lay audience? A population survey. BMC Med Inform Decis Mak (2007) 1.11
Adherence to preventive statin therapy according to socioeconomic position. Eur J Clin Pharmacol (2013) 0.95
Family practice patients' adherence to statin medications. Can Fam Physician (2007) 0.94
Adherence to lipid-lowering treatment: the patient perspective. Patient Prefer Adherence (2012) 0.89
Lipid-lowering drugs as primary prevention in general practice: do patients reach guideline goals and continue treatment? ADDITION Denmark. Scand J Prim Health Care (2011) 0.88
A population-based study of dosing and persistence with anti-dementia medications. Eur J Clin Pharmacol (2013) 0.84
Persistence with statin therapy in Hungary. Arch Med Sci (2013) 0.83
Is the high-risk strategy to prevent cardiovascular disease equitable? A pharmacoepidemiological cohort study. BMC Public Health (2012) 0.82
Long-term statin treatment in children with familial hypercholesterolemia: more insight into tolerability and adherence. Paediatr Drugs (2015) 0.81
Does the use of an electronic reminder device with or without counseling improve adherence to lipid-lowering treatment? The results of a randomized controlled trial. Front Pharmacol (2013) 0.80
Predictors of first-year statin medication discontinuation: A cohort study. J Clin Lipidol (2016) 0.80
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage. Br J Clin Pharmacol (2006) 0.79
Adherence to changing from brand-name to generic atorvastatin in newly treated patients: a retrospective cohort study using health insurance claims. J Pharm Health Care Sci (2015) 0.78
Influence of baseline low-density lipoprotein cholesterol values on statin therapy persistence. Eur J Clin Pharmacol (2015) 0.77
Overcoming Challenges With Statin Therapy. J Am Heart Assoc (2016) 0.76
Family history of cardiovascular disease and influence on statin therapy persistence. Eur J Clin Pharmacol (2014) 0.76
Over-the-counter fish oil use in a county hospital: Medication use evaluation and efficacy analysis. J Clin Lipidol (2015) 0.75
Do women with overactive bladder have realistic expectations for therapy? Int Urogynecol J (2010) 0.75
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet (2002) 44.28
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet (1994) 40.72
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med (1995) 28.35
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med (1996) 23.76
Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med (2000) 12.83
Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ (2003) 11.21
Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA (2002) 8.30
Long-term persistence in use of statin therapy in elderly patients. JAMA (2002) 7.19
Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA (2002) 6.30
Persistence of use of lipid-lowering medications: a cross-national study. JAMA (1998) 4.15
The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Québec. J Clin Epidemiol (1995) 3.99
Recall accuracy for prescription medications: self-report compared with database information. Am J Epidemiol (1995) 3.33
Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings? N Engl J Med (1995) 3.29
Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med (2002) 2.85
Reliability of recall of drug usage and other health-related information. Am J Epidemiol (1982) 2.81
A comparison of pregnancy history recall and medical records. Implications for retrospective studies. Am J Epidemiol (1985) 2.65
Risk for myopathy with statin therapy in high-risk patients. Arch Intern Med (2003) 2.56
Apparent discontinuation rates in patients prescribed lipid-lowering drugs. Med J Aust (1996) 1.94
Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research. J Clin Epidemiol (1994) 1.61
Treating hyperlipidemia for the primary prevention of coronary disease. Are higher dosages of lovastatin cost-effective? Arch Intern Med (1998) 1.48
High persistence of statin use in a Danish population: compliance study 1993-1998. Br J Clin Pharmacol (2002) 1.42
Impact of treating hyperlipidemia or hypertension to reduce the risk of death from coronary artery disease. CMAJ (1999) 1.24
Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in primary care. J Intern Med (1998) 1.18
Comparison of questionnaire information and pharmacy data on drug use. Pharm Weekbl Sci (1991) 1.06
Efficacy and cost of HMG-CoA reductase inhibitors in the treatment of patients with primary hyperlipidemia. Can J Clin Pharmacol (2000) 0.77
Drug injection among street youths in Montreal: predictors of initiation. J Urban Health (2003) 3.02
Isotretinoin and the risk of depression in patients with acne vulgaris: a case-crossover study. J Clin Psychiatry (2008) 2.22
First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage. Birth Defects Res B Dev Reprod Toxicol (2007) 2.06
Determinants of the incidence of childhood asthma: a two-stage case-control study. Am J Epidemiol (2008) 1.78
A cohort study showed that health insurance databases were accurate to distinguish chronic obstructive pulmonary disease from asthma and classify disease severity. J Clin Epidemiol (2005) 1.76
Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs. Med Care (2010) 1.57
HIV risk profile and prostitution among female street youths. J Urban Health (2002) 1.44
Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: A nested case-control study. Birth Defects Res B Dev Reprod Toxicol (2006) 1.37
Predictors of initiation into prostitution among female street youths. J Urban Health (2004) 1.31
Dosage of enoxaparin among obese and renal impairment patients. Thromb Res (2004) 1.22
Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention. Stroke (2008) 1.21
Training family physicians in shared decision making for the use of antibiotics for acute respiratory infections: a pilot clustered randomized controlled trial. Health Expect (2011) 1.17
Persistence, adherence, and effectiveness of combination therapy among adult patients with asthma. J Allergy Clin Immunol (2006) 1.17
Agreement between administrative databases and medical charts for pregnancy-related variables among asthmatic women. Pharmacoepidemiol Drug Saf (2008) 1.14
Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective. Br J Clin Pharmacol (2007) 1.13
Persistence with treatment in newly treated middle-aged patients with essential hypertension. Ann Pharmacother (2005) 1.12
Does training family physicians in shared decision making promote optimal use of antibiotics for acute respiratory infections? Study protocol of a pilot clustered randomised controlled trial. BMC Fam Pract (2007) 1.11
Cessation of injecting drug use among street-based youth. J Urban Health (2005) 1.11
Impact of better adherence to statin agents in the primary prevention of coronary artery disease. Eur J Clin Pharmacol (2009) 1.11
Impact of adherence to statins on coronary artery disease in primary prevention. Br J Clin Pharmacol (2007) 1.11
Ideal and actual involvement of community pharmacists in health promotion and prevention: a cross-sectional study in Quebec, Canada. BMC Public Health (2012) 1.09
A cluster randomized controlled Trial to Evaluate an Ambulatory primary care Management program for patients with dyslipidemia: the TEAM study. CMAJ (2010) 1.09
Effect of an educational intervention on optimizing antibiotic prescribing in long-term care facilities. J Am Geriatr Soc (2007) 1.09
Intraoperative floppy-iris syndrome associated with alpha1-adrenoreceptors: comparison of tamsulosin and alfuzosin. J Cataract Refract Surg (2007) 1.08
Feasibility of a randomised trial of a continuing medical education program in shared decision-making on the use of antibiotics for acute respiratory infections in primary care: the DECISION+ pilot trial. Implement Sci (2011) 1.07
Effect of theophylline on the rate of moderate to severe exacerbations among patients with chronic obstructive pulmonary disease. Br J Clin Pharmacol (2007) 1.07
Comment on "Association between the part D coverage gap and adverse health outcomes". J Am Geriatr Soc (2013) 1.06
Community pharmacists' interventions in asthma care: a descriptive study. Ann Pharmacother (2008) 1.05
Clinical effectiveness of inhaled corticosteroids versus montelukast in children with asthma: prescription patterns and patient adherence as key factors. Curr Med Res Opin (2011) 1.05
Impact of a continuing education program on community pharmacists' interventions and asthma medication use: a pilot study. Ann Pharmacother (2007) 1.02
Effect of statin adherence on cerebrovascular disease in primary prevention. Am J Med (2009) 1.01
Use of alternative and complementary therapies in children with cancer. Pediatr Blood Cancer (2005) 1.00
Results of a national survey on over-the-counter medicines, Part 1: Pharmacist opinion on current scheduling status. Can Pharm J (Ott) (2012) 0.99
Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication. Pharmacoepidemiol Drug Saf (2007) 0.99
The impact of a multidisciplinary information technology-supported program on blood pressure control in primary care. Circ Cardiovasc Qual Outcomes (2009) 0.99
Physician-pharmacist collaborative care in dyslipidemia management: the perception of clinicians and patients. Res Social Adm Pharm (2010) 0.99
Long circulating poly(ethylene glycol)-decorated lipid nanocapsules deliver docetaxel to solid tumors. Pharm Res (2006) 0.98
Use of inhaled corticosteroids during pregnancy and risk of pregnancy induced hypertension: nested case-control study. BMJ (2005) 0.98
Risk perception and reasons for noncompliance in pharmacovigilance: a qualitative study conducted in Canada. Drug Saf (2009) 0.97
Adherence to antihypertensive agents improves risk reduction of end-stage renal disease. Kidney Int (2013) 0.96
Factors associated with psychotropic drug use among community-dwelling older persons: A review of empirical studies. BMC Nurs (2004) 0.94
Action plans in asthma. Can Respir J (2006) 0.94
Work-exacerbated asthma and occupational asthma: do they really differ? J Allergy Clin Immunol (2012) 0.94
Results of a national survey on OTC medicines, Part 2: Do pharmacists support switching prescription agents to over-the-counter status? Can Pharm J (Ott) (2012) 0.94
Effect of maternal moderate to severe asthma on perinatal outcomes. Respir Med (2010) 0.93
Healthcare professionals' adoption and use of a clinical information system (CIS) in primary care: insights from the Da Vinci study. Int J Med Inform (2011) 0.92
Impact of adherence to statins on chronic heart failure in primary prevention. Br J Clin Pharmacol (2008) 0.91
Treatment persistence with leukotriene receptor antagonists and inhaled corticosteroids. J Asthma (2005) 0.90
Knowledge, attitudes and beliefs about chronic noncancer pain in primary care: a Canadian survey of physicians and pharmacists. Pain Res Manag (2014) 0.90
Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women. Br J Clin Pharmacol (2008) 0.90
Suboptimal use of inhaled corticosteroids in children with persistent asthma: inadequate prescription, poor drug adherence, or both? Pharmacotherapy (2010) 0.90
Development and validation of database indexes of asthma severity and control. Thorax (2007) 0.88
Adherence to antihypertensive agents after ischemic stroke and risk of cardiovascular outcomes. Neurology (2012) 0.88
Relationship between adherence level to statins, clinical issues and health-care costs in real-life clinical setting. Value Health (2009) 0.88
Adherence level of antihypertensive agents in coronary artery disease. Br J Clin Pharmacol (2010) 0.87
Is long-term pharmacist-managed anticoagulation service efficient? A pragmatic randomized controlled trial. Am Heart J (2008) 0.87
Community pharmacy-based medication assessment program for asthma and chronic obstructive pulmonary disease. Can Pharm J (Ott) (2012) 0.87
Beta2-agonists use during pregnancy and the risk of congenital malformations. Birth Defects Res A Clin Mol Teratol (2011) 0.86
Reliability, validity and ease of use of a portable point-of-care coagulation device in a pharmacist-managed anticoagulation clinic. J Thromb Thrombolysis (2002) 0.86
The willingness of community pharmacists to participate in a practice-based research network. Can Pharm J (Ott) (2013) 0.86
Scientific rigour and innovations in participatory action research investigating workplace learning in continuing interprofessional education. J Interprof Care (2014) 0.85
Does clinical trial subject selection restrict the ability to generalize use and cost of health services to "real life" subjects? Int J Technol Assess Health Care (2003) 0.85
Effectiveness and cost-effectiveness of antibiotic treatments for community acquired pneumonia (CAP) and acute exacerbations of chronic bronchitis (AECB). Can J Clin Pharmacol (2005) 0.85
Predictors of preoperative delays before radical cystectomy for bladder cancer in Quebec, Canada: a population-based study. BJU Int (2014) 0.85
Social context, the struggle with uncertainty, and subjective risk as meaning-rich constructs for explaining HBP noncompliance. Patient Educ Couns (2007) 0.84
Unconventional indicators of drug dependence among elderly long-term users of benzodiazepines. Issues Ment Health Nurs (2004) 0.84
Research method issue: recruiting and retaining subjects in a research study. Nurse Res (2008) 0.84
Use of over-the-counter medications and natural products in patients with moderate and severe chronic renal insufficiency. Am J Kidney Dis (2007) 0.84
Characteristics and medical resource use of asthmatic subjects with and without work-related asthma. J Allergy Clin Immunol (2007) 0.83
Physician-pharmacist collaborative care for dyslipidemia patients: knowledge and skills of community pharmacists. J Contin Educ Health Prof (2009) 0.83
Management of chronic obstructive pulmonary disease in patients admitted to a tertiary care centre for exacerbation of their disease. Can J Hosp Pharm (2012) 0.83
Development and validation of the PAIR (Pharmacotherapy Assessment in Chronic Renal Disease) criteria to assess medication safety and use issues in patients with CKD. Am J Kidney Dis (2011) 0.83
The impact of the type of insurance plan on adherence and persistence with antidepressants: a matched cohort study. Can J Psychiatry (2013) 0.82
Population-based study of the effectiveness of bone-specific drugs in reducing the risk of osteoporotic fracture. Pharmacoepidemiol Drug Saf (2008) 0.82
Discontinuation of antiresorptive therapies: a comparison between 1998-2001 and 2002-2004 among osteoporotic women. J Clin Endocrinol Metab (2007) 0.82
Effect of fetal gender on maternal asthma exacerbations in pregnant asthmatic women. Respir Med (2008) 0.82